MedTrace Logo

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

NCT05406934 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-06-07

No results posted yet for this study

Summary

ulcerative colitis and Crohn's disease, the two major forms of inflammatory bowel disease, are chronic, idiopathic, relapsing inflammatory conditions of the gastrointestinal tract. The mechanism is multifactorial and may result from the combined interaction of environmental, genetic, epithelial barrier defects, dysregulated immune responses, and microbial factors

Conditions

  • Bowel Disease
  • Inflammatory Bowel Diseases

Interventions

BIOLOGICAL

Infliximab

obseravation with investigation

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-05
Primary Completion
2022-06-05
Completion
2024-10-31
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406934 on ClinicalTrials.gov